Get started
BMC MEDICAL CO LTDBB

BMC MEDICAL CO LTD

84.58CNYD
−3.10−3.54%
At close at May 30, 08:49 GMT
CNY
No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Forecast Seasonals

301367 fundamentals

Key facts

Market capitalization‪10.38 B‬CNY
Dividend yield (indicated)0.47%
Price to earnings Ratio (TTM)44.00
Basic EPS (TTM)1.99CNY
Founded2001
Employees (FY)‪1.2 K‬
CEOZhi Zhuang
Websitebmc-medical.com
About

BMC Medical Co. Ltd. principally engages in the research, development, production, and sale of medical equipment and consumable products in the field of respiratory health. It also offers chronic respiratory disease management services. Its key products include household non-invasive ventilators, ventilation masks, sleep monitors, and high-flow humidified oxygen therapy devices. The company was founded by Zhi Zhuang on July 27, 2001 and is headquartered in Beijing, China.

Ownership
‪‪88.91 M‬‬
Closely held shares
‪‪49.04 M‬‬ (55.16%)
Free Float shares
‪‪39.86 M‬‬ (44.84%)
Closely held shares
‪‪49.04 M‬‬ (55.16%)
Free Float shares
‪‪39.86 M‬‬ (44.84%)
Capital structure
Market cap
‪‪10.38 B‬‬
Debt
‪‪316.67 M‬‬
Minority interest
‪‪8.05 M‬‬
Cash & equivalents
‪‪2.81 B‬‬
Enterprise value
‪‪7.89 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪10.38 B‬‬
Price to earning ratio (P/E)
44.00x
Price to sales ratio (P/S)
8.59x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
44.00x
Price to sales ratio (P/S)
8.59x
Valuation ratios
‪0.00‬
‪2.50‬
‪5.00‬
‪7.50‬
‪10.00‬
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪12.00‬
‪24.00‬
‪36.00‬
‪48.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪10%‬
‪15%‬
‪20%‬
‪25%‬
‪30%‬
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪‪70.00 M‬‬
‪‪140.00 M‬‬
‪‪210.00 M‬‬
‪‪280.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪70.00 M‬‬
‪‪140.00 M‬‬
‪‪210.00 M‬‬
‪‪280.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪70.00 M‬‬
‪‪140.00 M‬‬
‪‪210.00 M‬‬
‪‪280.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Home Respiratory Care Products
Consumables
Medical Product
Other
By country
Period: 2024
Overseas
China

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪‪70.00 M‬‬
‪‪140.00 M‬‬
‪‪210.00 M‬‬
‪‪280.00 M‬‬
Actual
Earnings
Next:Mar 26, 2026
2022
2023
2024
2025
‪0.00‬
‪1.30‬
‪2.60‬
‪3.90‬
‪5.20‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

Dividend summary
20.07%
Earnings retained
Payout ratio (TTM)
Dividend yield TTM
0.47%
Last payment
0.40
Last ex-date
May 28, 2025
Last pay date
May 28, 2025
Dividend history
‪0.60%‬
‪0.68%‬
‪0.76%‬
‪0.84%‬
‪0.92%‬
2020
2021
2022
2023
2024
‪0.00‬
‪0.40‬
‪0.80‬
‪1.20‬
‪1.60‬
Dividends per share (FY)
Dividend yield (FY) %

Financial health

Financial position and solvency of the company

Debt level and coverage
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪‪−300.00 M‬‬
‪0.00‬
‪‪300.00 M‬‬
‪‪600.00 M‬‬
‪‪900.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪800.00 M‬‬
‪‪1.60 B‬‬
‪‪2.40 B‬‬
‪‪3.20 B‬‬
Assets
Liabilities